                         SEQUENCE LISTING

<110>  INSERM
 
<120>  METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF
        CANCER

<130>  BIO11420 SUSIN

<160>  5     

<170>  PatentIn version 3.3

<210>  1
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  1

Lys Arg Phe Tyr Val Val Met Trp Lys Lys 
1               5                   10  


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Peptide

<400>  2

Lys Arg Phe Tyr Gly Gly Met Trp Lys Lys 
1               5                   10  


<210>  3
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  3

Arg Phe Tyr Val Val Met Trp Lys 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  4

Lys Trp Met Val Val Tyr Phe Arg 
1               5               


<210>  5
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  peptide

<400>  5

Lys Lys Trp Met Val Val Tyr Phe Arg Lys 
1               5                   10  


